1st Amendment Looms Large Over FDA's Twitter Rules
The U.S. Food and Drug Administration's newly minted restrictions on pharmaceutical promotion via Twitter are vulnerable to a First Amendment attack, according to scholars who say drugmakers may be able to...To view the full article, register now.
Already a subscriber? Click here to view full article